Sources | Names Used |
---|---|
CCLE, GDSC1000, FIMM | Nilotinib |
CTRPv2 | nilotinib |
PharmacoGx | Nilotinib |
Database | Identifier |
---|---|
Smiles: | CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Inchikey: | HHZIURLSWUIHRB-UHFFFAOYSA-N |
Pubchem: | 644241 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABCB10 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | ABCC4 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | ABCC4 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
mRNA | ABCC8 | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
mRNA | ABHD5 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ABHD6 | CCLE | pan-cancer | AAC | -0.2 | 0.0002 |
mRNA | ABL1 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | ABL1 | CCLE | pan-cancer | AAC | 0.26 | 2e-07 |
mRNA | ABL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |